The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapies

Nazeer Ahmed, Fatima Jawaid, Muhammad Nabeel

Open source

DOI
10.1080/1750743x.2026.2698221
Published
2026-06-13
Container
Immunotherapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/1750743x.2026.2698221,
  title = {The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapies},
  author = {Nazeer Ahmed and Fatima Jawaid and Muhammad Nabeel},
  year = {2026},
  journal = {Immunotherapy},
  doi = {10.1080/1750743x.2026.2698221},
  url = {https://doi.org/10.1080/1750743x.2026.2698221}
}

RIS

TY  - JOUR
TI  - The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapies
AU  - Nazeer Ahmed
AU  - Fatima Jawaid
AU  - Muhammad Nabeel
PY  - 2026
JO  - Immunotherapy
DO  - 10.1080/1750743x.2026.2698221
UR  - https://doi.org/10.1080/1750743x.2026.2698221
ER  - 

APA

Ahmed, N., Jawaid, F., & Nabeel, M. (2026). The dual legacy of BCG: a century of tuberculosis prevention and the evolving pursuit of trained immunity-based therapies. Immunotherapy. https://doi.org/10.1080/1750743x.2026.2698221

Source records